Published in Arch Med Sci on April 23, 2015
The role of micronutrients in the risk of urinary tract cancer. Arch Med Sci (2016) 0.78
Socioeconomic determinants of prostate-specific antigen testing and estimation of the prevalence of undiagnosed prostate cancer in an elderly Polish population based on the PolSenior study. Arch Med Sci (2016) 0.75
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 35.39
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev (2006) 4.02
Diabetes and cancer: a consensus report. CA Cancer J Clin (2010) 3.95
Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72
Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst (1995) 3.67
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol (2008) 3.62
A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst (1993) 3.40
Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res (1991) 3.24
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer (1991) 3.14
A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2006) 3.13
The risk of cancer in users of statins. J Clin Oncol (2004) 3.01
Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia (2006) 2.91
Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr (2002) 2.75
Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol (2011) 2.51
Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med (1992) 2.43
Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study. Arch Surg (2005) 2.39
Statin use and cancer risk in the General Practice Research Database. Br J Cancer (2004) 2.34
Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev (2006) 2.28
Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev (2001) 2.17
Statins and cancer: A systematic review and meta-analysis. Eur J Cancer (2008) 2.15
Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer (2010) 2.13
Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. J Urol (2010) 2.03
Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst (1997) 1.98
Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol (2011) 1.85
Statin use and risk of prostate cancer: a meta-analysis of observational studies. PLoS One (2012) 1.74
Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control (2002) 1.66
Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol (2008) 1.64
The correlation of nutrition risk index, nutrition risk score, and bioimpedance analysis with postoperative complications in patients undergoing gastrointestinal surgery. Surgery (2009) 1.63
Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol (1984) 1.60
Epidemiology of adenocarcinoma of the kidney. J Natl Cancer Inst (1974) 1.58
Statin use and cancer risk: a comprehensive review. Expert Opin Drug Saf (2010) 1.56
Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol (2004) 1.54
Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis. J Urol (2003) 1.52
Obesity and renal cell cancer--a quantitative review. Br J Cancer (2001) 1.51
International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer (1986) 1.51
Declining mortality from bladder cancer in Europe. BJU Int (2007) 1.49
The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int (2008) 1.49
The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia (1999) 1.45
The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol (1991) 1.45
Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control (1997) 1.36
Leveling of prostate cancer mortality in Western Europe. Prostate (2004) 1.34
A prospective study of diet, smoking, and lower urinary tract cancer. Ann Epidemiol (1993) 1.32
The effects of adjusting for case mix on mortality and length of stay following radical cystectomy. J Urol (2006) 1.31
Exposure to statins and risk of common cancers: a series of nested case-control studies. BMC Cancer (2011) 1.29
Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies. Prostate Cancer Prostatic Dis (2012) 1.28
Incidence of colorectal cancer in Poland in 1999-2008. Arch Med Sci (2011) 1.25
Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer (1998) 1.24
Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol (2000) 1.21
Insulin-like growth factor I (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: possible mediators for the effects of diet and exercise on cancer cell survival. Endocrinology (2003) 1.20
Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol (Oxf) (1997) 1.19
Obesity and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev (1996) 1.19
Geographic patterns of prostate cancer in the United States. J Natl Cancer Inst (1978) 1.17
Body size and composition and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2003) 1.16
Vitamin A supplements, fried foods, fat and urothelial cancer. A case-referent study in Stockholm in 1985-87. Int J Cancer (1990) 1.16
Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology (1999) 1.16
Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev (2008) 1.15
History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control (2007) 1.15
Cachexia-like symptoms predict a worse prognosis in localized t1 renal cell carcinoma. J Urol (2004) 1.12
Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev (1998) 1.11
International trends in prostatic cancer. Int J Cancer (1984) 1.09
Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer (2007) 1.06
Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men. J Urol (2007) 1.02
Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer (2008) 1.02
Diet and bladder cancer in Spain: a multi-centre case-control study. Int J Cancer (1991) 1.02
Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults. Arch Med Sci (2013) 0.99
Alcohol intake and risk of renal cell carcinoma: a meta-analysis of published case-control studies. Arch Med Sci (2011) 0.99
Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study. Eur J Clin Nutr (1994) 0.98
Consumption of different types of meat and the risk of renal cancer: meta-analysis of case-control studies. Cancer Causes Control (2007) 0.96
Diabetes mellitus and kidney cancer risk: the results of Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study). Int J Urol (2007) 0.95
Quantitative assessment of red meat or processed meat consumption and kidney cancer. Cancer Detect Prev (2009) 0.95
The incidence of acute myocardial infarction in relation to overweight and obesity: a meta-analysis. Arch Med Sci (2014) 0.93
Complications of radical cystectomy and correlation with nutritional assessment. Urology (1986) 0.89
Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study. Arch Med Sci (2013) 0.88
Consumption of animal products, olive oil and dietary fat and results from the Belgian case-control study on bladder cancer risk. Eur J Cancer (2010) 0.86
Cancer progression in the transgenic adenocarcinoma of mouse prostate mouse is related to energy balance, body mass, and body composition, but not food intake. Cancer Res (2006) 0.86
Hypogonadism and diabetes. Int J Impot Res (2003) 0.85
Ischemic heart disease precipitated by occult cancer. Cancer (1992) 0.85
Diet and bladder cancer: a case-control study. Int Urol Nephrol (2005) 0.84
Signaling to a B-cell clone by Ek, but not Ak, does not reflect alteration of Ak genes. Immunogenetics (1988) 0.81
Nutritional status of patients with cancer of the bladder before and during radiation therapy. Influence on survival? Radiother Oncol (1986) 0.81
Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention? Urol Clin North Am (2004) 0.80
Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties. Int J Mol Sci (2012) 0.79
Docosahexaenoic acid reduces in vitro invasion of renal cell carcinoma by elevated levels of tissue inhibitor of metalloproteinase-1. J Nutr Biochem (2005) 0.79
Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancer. Urol Oncol (2008) 0.76
Laparoscopic radical prostatectomy with bladder neck preservation: positive surgical margin and urinary continence status. Wideochir Inne Tech Maloinwazyjne (2014) 0.92
Modified technique for laparoscopic running vesicourethral anastomosis. Wideochir Inne Tech Maloinwazyjne (2014) 0.88
Is determination of transition zone volume by transrectal ultrasound in patients with clinically benign prostatic enlargement sufficiently reliable in the clinical setting? Wideochir Inne Tech Maloinwazyjne (2014) 0.79
The role of micronutrients in the risk of urinary tract cancer. Arch Med Sci (2016) 0.78
Transoesophageal echocardiography reduces invasiveness of cavoatrial tumour thrombectomy. Wideochir Inne Tech Maloinwazyjne (2014) 0.77
Evaluation and management of male lower urinary tract symptoms: treatment patterns and guidelines in a correlation study among Polish urology consultants. Arch Med Sci (2015) 0.75
Laparoscopic urinary bladder diverticulectomy combined with photoselective vaporisation of the prostate. Wideochir Inne Tech Maloinwazyjne (2015) 0.75